0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
From the Centers for Disease Control and Prevention |

National, State, and Urban Area Vaccination Coverage Among Children Aged 19-35 Months—United States, 2004 FREE

JAMA. 2005;294(12):1485-1486. doi:10.1001/jama.294.12.1485.
Text Size: A A A
Published online

MMWR. 2005;54:717-721

2 tables omitted

The National Immunization Survey (NIS) provides vaccination coverage estimates for children aged 19-35 months for each of the 50 states and 28 selected urban areas.* This report summarizes results from the 2004 NIS,† which indicated nationwide increases in coverage with at least 1 dose of varicella vaccine (VAR), pneumococcal conjugate vaccine (PCV), and the 4:3:1,‡ 4:3:1:3:3,§ and 4:3:1:3:3:1∥ vaccine series. These levels represent an important accomplishment by exceeding for the first time the Healthy People 2010 goal of ≥80% coverage for the 4:3:1:3:3 vaccine series.

To collect vaccination data for age-eligible children, NIS uses a quarterly random-digit–dialing sample of telephone numbers for each of the 78 survey areas. NIS methodology, including the weighting of responses to represent the entire population of children aged 19-35 months, has been described previously.1 During 2004, health-care provider vaccination records were obtained for 21,998 children. The overall survey response rate for eligible households was 67.4%.

National coverage estimates increased from 2003 to 2004 for two of the more recently implemented vaccines, VAR and PCV. Coverage estimates for all other vaccines were not substantially different from 2003 to 2004. For the combined vaccine series 4:3:1, 4:3:1:3:3, and 4:3:1:3:3:1, national coverage increased from 2003 to 2004.

However, as in previous years, estimated vaccination coverage levels still varied substantially among states. Estimated coverage with the 4:3:1:3:3 series ranged from 89.1% in Massachusetts to 68.4% in Nevada. Coverage also ranged substantially among the 28 urban areas. The highest estimated coverage among the urban areas for the 4:3:1:3:3 series was 89.7% for Davidson County, Tennessee, and the lowest was 64.8% for El Paso County, Texas.

Reported by:

N Darling, MPH, T Santibanez, PhD, J Santoli, MD, Immunization Svcs Div, National Immunization Program, CDC.

CDC Editorial Note:

The findings in this report indicate that, for the first time, vaccination coverage (80.9%) for the 4:3:1:3:3 series exceeded the Healthy People 2010 goal (objective 14-24a)2 to increase to at least 80% the proportion of children aged 19-35 months who receive all vaccines recommended for universal administration for at least 5 years. Beginning with next year’s report on the 2005 NIS, the series measure 4:3:1:3:3:1 (76.0% in 2004) will be used to evaluate progress toward the Healthy People 2010 goal because, beginning with the survey cohort, varicella vaccination will have been recommended for universal administration for 5 years.

The vaccination coverage levels described in this report are notable given shortages in the supplies of several vaccines during 2001-2004. For example, DTaP shortages persisted for more than 1 year, beginning in March 2001 and resolving by July 2002. Shortages for PCV also began in mid-year 2001 and ended in May 2003, only to become short again in early 2004; the PCV shortage ended in September 2004.3-5 Because vaccine supply shortages are likely to reoccur,6,7 as evidenced by the shortages of influenza vaccine during both the 2003-04 and 2004-05 influenza seasons,8,9 strategies to manage vaccine supply and continued monitoring of the effects of shortages on coverage are needed.

The findings in this report are subject to at least three limitations. First, NIS is a telephone survey; although NIS results are weighted to make them representative of all children aged 19-35 months, these statistical adjustments might not fully represent all the complexities of the survey (e.g., accounting for nonresponse and households without telephones). Second, NIS uses provider-verified vaccination histories and assumes that coverage among children whose providers did not respond is similar to that among children whose providers did respond; thus, incomplete reporting might have resulted in underestimates of coverage. Third, although national estimates are precise,10 estimates for states and urban areas should be interpreted with caution because of wider confidence intervals.

NIS is routinely used to monitor vaccination status among preschool-aged children; however, NIS could be expanded for measuring vaccination coverage among other age groups and for newer vaccines as they become licensed and recommended. In a 2004 pilot study, NIS was used to estimate vaccination coverage among adolescents; analysis of these data is ongoing. In 2003 and 2004, another expansion of NIS, the National Adult Immunization Survey (NAIS), was used to assess influenza and pneumococcal polysaccharide vaccination coverage and reasons for nonvaccination among adults aged ≥50 years. In 2004, NIS began measuring influenza vaccination coverage among children aged 6-23 months. Several vaccines are newly recommended for various age groups (e.g., meningococcal conjugate [MCV4] and tetanus, diphtheria, and acellular pertussis [Tdap] vaccines) with several others likely to be licensed in the near future (e.g., measles-mumps-rubella-varicella [MMRV], rotavirus, human papillomavirus [HPV], and zoster vaccines). These developments underscore the importance of survey systems such as NIS in monitoring new vaccine implementation, which in turn can provide valuable information for enhancing vaccine uptake.

REFERENCES: 10 available

*Jefferson County, Alabama; Maricopa County, Arizona; Los Angeles, San Diego, and Santa Clara counties, California; District of Columbia; Miami-Dade and Duval counties, Florida; Fulton/Dekalb counties, Georgia; Chicago, Illinois; Marion County, Indiana; Orleans Parish, Louisiana; Baltimore, Maryland; Boston, Massachusetts; Detroit, Michigan; Newark, New Jersey; New York, New York; Cuyahoga and Franklin counties, Ohio; Philadelphia County, Pennsylvania; Davidson and Shelby counties, Tennessee; Bexar, Dallas, and El Paso counties, and Houston, Texas; King County, Washington; and Milwaukee County, Wisconsin.

†During the 2004 reporting period, NIS included children born during February 2001–June 2003.

‡≥4 doses of diphtheria, tetanus toxoids and pertussis vaccines, diphtheria and tetanus toxoids, and diphtheria, tetanus toxoids and any acellular pertussis vaccine (DTP/DT/DTaP); ≥3 doses of poliovirus vaccine; and ≥1 dose of any measles-containing vaccine.

§4:3:1 plus ≥3 doses of Haemophilus influenzae type b (Hib) vaccine and ≥3 doses of hepatitis B vaccine.

∥4:3:1:3:3 plus ≥1 dose of VAR.

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles